AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...

Emblaveo is the second antibiotic approved for problem pathogens in the EU this year, raising hopes that after years of neglect due to the difficulty of getting a return on R&D investment for ...

A positive outlook for 2025, including the licensing of an obesity drug and FDA approval of Emblaveo, added support. AstraZeneca performed well, driven by ongoing strength in oncology, ...

Get today's Pfizer DRC stock news. We cover the latest Pfizer DRC headlines and breaking news impacting Pfizer DRC stock performance.

Although rare, residual tip appendicitis should be considered in the differential diagnosis of localized peritonitis in patients who have undergone previous appendectomy.

Intestinal protozoa are responsible for considerable morbidity and mortality associated with diarrheal disease in both the developed and developing world. Many of these infections are particularly ...

Investing.com -- Shares of Xilio Therapeutics Inc surged 175% on Wednesday in pre-market trading following the announcement of a ...

Find the latest Zhejiang Whyis Technology Co.,Ltd. (301218.SZ) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest (084098.TW) stock quote, history, news and other vital information to help you with your stock trading and investing.

The connection between humans and Nature’s chemistry is astonishing and built into the very fabric of our genetic code. In this Perspective, we focus on bioactive molecules from microbes, plants, and ...